Dr. Agarwal's Health Care enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
15,482——
243243367
94.294.260.2
157157247
15,491——
−85.6−85.6−120
₹488.97——
2,2772,2772,174
6.9%6.9%11.4%
0.01×——
7.02×——
25.31×——
48.33×——
265.21×——
Reference items — trailing FY values
2,2072,0801,711
612570456
321293226
—519360
58.458.439.4
—55.829.5
—461321
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AGARWALEYE₹488.70

Dr. Agarwal's Health Care Ltd.

· Pharma & Health
₹ CrorePeersAKUMSADVENZYMESALIVUSAARTIPHARMAARTIDRUGSAPLLTDCORONAHCGMcap ₹15,482 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization——15,482.0
- Cash, Equiv & ST Investments367.3242.9242.9
+ Minority Interest60.294.294.2
+ Total Debt246.9157.3157.3
Enterprise Value——15,490.6
Net Debt (memo)-120.5-85.6-85.6
EV per Share——488.97
Total Capital2,173.72,277.02,277.0
Total Debt/Total Capital11.366.916.91
Total Debt/EV——0.01
EV/Sales——7.02
EV/EBITDA——25.31
EV/EBIT——48.33
EV/Free Cash Flow——265.21
Reference Items — Trailing FY Values
Sales1,711.02,080.12,206.7
EBITDA456.4569.6612.1
EBIT225.6293.3320.5
Operating Cash Flow360.3519.0—
Free Cash Flow39.458.458.4
FCFF (free cash flow to the firm)29.555.8—
Capital Expenditure320.9460.6—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.